News - BioPharm International



ISPE Releases its Drug Shortages Prevention Plan

October 15, 2014

The International Society for Pharmaceutical Engineering (ISPE) released its Drug Shortages Prevention Plan as part of an initiative to address drug shortage prevention due to manufacturing and quality issues.

Report Explores Factors Contributing to Success and Failure in Cancer Treatments

October 14, 2014

A report from PhRMA highlights how drugs that failed in clinical trials are a crucial part of development for melanoma, lung cancer, and brain cancer.

Endo to Acquire Auxilium Pharmaceuticals

October 10, 2014

Endo will acquire Auxilium Pharmaceuticals in a cash and stock transaction for approximately $2.6 billion.

IDT Biologika Certifies Facility to Fill and Lyophilize Biologics and Vaccines

October 10, 2014

IDT Biologika completes large-scale biologics finishing facility in Dessau, Germany.

FUJIFILM Diosynth Biotechnologies Releases Mammalian Expression Platform

October 9, 2014

The Apollo platform can be used throughout a product?s entire lifecycle.

Amgen Reports Positive Phase III Results for Biosimilar of Humira

October 9, 2014

ABP 501, a biosimilar candidate for Humira, was shown to have a immunogenicity and efficacy profile comparable to that of the innovator product.

NIH Invests in Biomedical Research Data

October 9, 2014

The National Institutes of Health announces grants for the development of strategies for the utilization of biomedical data sets.

Ascension Health Bans Genentech Sales Reps After Losing Drug Discounts

October 7, 2014

A change in the supply chain for three important Genentech cancer medications elicits a strong reaction from one of the nation's largest operators of hospitals.

Salix Looks to Actavis After Terminating Cosmo Deal

October 6, 2014

New rules from the Treasury Department regarding inversion affect merger activity in the pharmaceutical sector.



Click here